More studies are needed to explore if overexpression of Plk1 correlates with loss of p53, non-functional p53 or gain-of-function (GOF) mutant p53 in tumor tissues, and if this correlation is linked to therapy resistance and poor prognosis of tumor patients. This evidence concerns the gene PLK1 and neoplasm.